Magnetic hydroxyapatite nanomaterial–cyclodextrin tethered polymer hybrids as anticancer drug carriers
Sivaraj Ramasamy, Dinesh Dhamecha, Kiruthiga Kaliyamoorthi, Archana Sumohan Pillai, Aleyamma Alexander, Premnath Dhanaraj, Jyothi U. Menon, Israel V.M.V. Enoch
Abstract
Osteosarcoma, the most common bone cancer, leads to a poor survival rate of patients. Drug targeting employing hydroxyapatite (HAp)-based nanocarriers represents a fascinating choice for non-invasive treatment of osteosarcoma.
Topics & Concepts
NanocarriersOsteosarcomaCyclodextrinDrugAnticancer drugNanomaterialsCancer researchMaterials scienceMedicineNanotechnologyChemistryPharmacologyBiochemistryBone Tissue Engineering MaterialsNanoparticle-Based Drug DeliveryGraphene and Nanomaterials Applications